Price Fluctuations and Impairment of Investment Securities
First written in FY2017. 10 of 25 entries say "Materialised", first in FY2018-Q3. Latest entry: FY2026.
Vector moved to the "Worse" side of this theme in 2018, 2 years before the typical company in this theme (2020).
The whole theme swung hardest in 2019: 31 of 92 companies on the "Worse" side.
11 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「During the consolidated fiscal year, impairment losses of ¥718 million were recognized on securities held for operating investment purposes, including ¥718 million on shares without a market price classified as other securities, and ¥188 million on investment securities.」
Impairment losses on securities held for operating investment purposes increased from ¥555 million in the previous fiscal year to ¥718 million, while impairment losses on investment securities increased from ¥110 million to ¥188 million. - FY2025MitigatedAnnual report
「During the consolidated fiscal year, impairment losses of ¥555 million were recognized on securities held for operating investment purposes, including ¥555 million on shares without a market price classified as other securities, and ¥110 million on investment securities.」
Valuation losses continued to be recognized, but impairment losses on securities held for operating investment purposes decreased from ¥865 million in the previous fiscal year to ¥555 million. Meanwhile, an impairment loss of ¥110 million was recognized on investment securities. - FY2025-H1MaterialisedAnnual report
「In the investment business, some of the shares held by the company were sold, while valuation losses were recognized on some investments.」
Valuation losses were also recognized on some investments during the interim period, demonstrating that the price fluctuation and impairment risks associated with investment securities are materializing. - FY2025-Q1MaterialisedAnnual report
「In the investment business, some of the shares held by the company were sold, while valuation losses were recognized on some investments.」
The price fluctuation and impairment risks associated with investments materialized during the quarter, with valuation losses recognized on some investments. - FY2024WorsenedAnnual report
「During the consolidated fiscal year, impairment losses of ¥865 million were recognized on securities held for operating investment purposes, including ¥798 million on shares without a market price classified as other securities, and ¥14 million on investment securities.」
Impairment losses on securities held for operating investment purposes increased from ¥621 million in the previous fiscal year to ¥865 million. An impairment loss of ¥14 million was also recognized on investment securities. - FY2023WorsenedAnnual report
「During the consolidated fiscal year, impairment losses of ¥621 million were recognized on securities held for operating investment purposes and ¥134 million on investment securities, including ¥64 million on shares without a market price classified as other securities.」
Valuation losses on investment securities and related assets were recognized, comprising impairment losses of ¥621 million on securities held for operating investment purposes and ¥134 million on investment securities. - FY2023-Q2MaterialisedAnnual report
「Investment securities valuation loss 64」
A valuation loss on investment securities of ¥64 million was recognized in the six-month period ended the second quarter, and the price fluctuation and impairment risks associated with investment securities materialized as actual losses. - FY2022MitigatedAnnual report
「In investing activities, the sale of shares held to improve the efficiency of its assets and strengthen its financial position resulted in a gain on the sale of investment securities of ¥642 million. However, valuation losses on investment securities of ¥745 million were recognized, mainly on some investments affected by COVID-19.」
The valuation loss on investment securities decreased from ¥1,054 million in the previous year to ¥745 million, but losses continued to be recognized. The company also continued to improve asset efficiency through the sale of shares held. - FY2022-Q3WorsenedAnnual report
「In investing activities, valuation losses on investment securities of ¥319 million were recognized mainly on some investments affected by COVID-19. However, the sale of shares held by the Group to improve the efficiency of its assets and strengthen its financial position resulted in a gain on the sale of investment securities of ¥503 million.」
The valuation loss on investment securities increased from ¥276 million for the six-month period ended the second quarter to ¥319 million, while the sale of shares held resulted in a gain on sale of ¥503 million. - FY2022-Q2WorsenedAnnual report
「In investing activities, the sale of shares held to improve the efficiency of its assets and strengthen its financial position resulted in a gain on the sale of investment securities of ¥70 million. However, valuation losses on investment securities of ¥276 million were recognized, mainly on some investments affected by COVID-19.」
While a gain of ¥70 million was recognized on the sale of shares held, the valuation loss on investment securities increased from ¥36 million for the three-month period ended the first quarter to ¥276 million, and valuation losses continued to be recognized. - FY2022-Q1MaterialisedAnnual report
「Investment securities valuation loss 36」
A valuation loss on investment securities of ¥36 million was recognized in the three-month period ended the first quarter, and the price fluctuation and impairment risks associated with investment securities continued to materialize as actual losses. - FY2021MitigatedAnnual report
「In investing activities, valuation losses on investment securities of ¥1,054 million were recognized mainly on some investments affected by COVID-19. However, the sale of 15 shares held by the Group, aimed at improving the efficiency of its assets and strengthening its financial position, resulted in a gain on the sale of investment securities of ¥1,674 million.」
Although valuation losses on investment securities were recognized, the sale of 15 shares resulted in a gain on sale of ¥1,674 million, while the company continued to improve asset efficiency and strengthen its financial position. - FY2021-Q3MitigatedAnnual report
「In investing activities, valuation losses on investment securities were recognized mainly on some investments affected by COVID-19 during the second-quarter consolidated accounting period. During the third-quarter consolidated accounting period, however, a gain on the sale of investment securities of ¥1,023 million was recognized through the sale of 7 shares held by the Group, with the aim of improving the efficiency of its assets and strengthening its financial position.」
While a valuation loss was recognized in the second quarter, 7 shares held were sold in the third quarter, resulting in a gain on the sale of investment securities of ¥1,023 million. - FY2021-Q2WorsenedAnnual report
「Investment securities valuation loss 764,406」
Valuation losses were recognized mainly on some investments affected by COVID-19, resulting in a valuation loss on investment securities of ¥764.406 million. - FY2020WorsenedAnnual report
「During the consolidated fiscal year, impairment losses of ¥288.431 million were recognized on securities held for operating investment purposes and ¥1,279.367 million on investment securities, comprising ¥1,279.367 million on unlisted shares classified as other securities.」
The valuation loss on investment securities was ¥1,279.367 million, up from ¥730.680 million in the previous fiscal year. A valuation loss of ¥288.431 million was also recognized on securities held for operating investment purposes. - FY2020-Q2MaterialisedAnnual report
「In investing activities, a gain on the sale of investment securities was generated through the sale of shares held, while valuation losses on investment securities were recognized for some investments.」
A valuation loss on investment securities of ¥513.582 million was recognized, up from ¥235.665 million in the six-month period of the previous fiscal year. The price fluctuation and impairment risks continue to materialize as actual losses. - FY2019WorsenedAnnual report
「During the consolidated fiscal year, impairment losses of ¥99 million were recognized on securities held for operating investment purposes and ¥730.680 million on investment securities, comprising ¥730.680 million on unlisted shares classified as other securities.」
The valuation loss on investment securities was ¥730.680 million, up from ¥293.458 million in the previous fiscal year. A valuation loss of ¥99 million was also recognized on securities held for operating investment purposes. - FY2019-Q3WorsenedAnnual report
「Investment securities valuation loss 240,665」
The valuation loss on investment securities was ¥240.665 million for the nine-month period ended the third quarter, up from ¥39.999 million in the same period of the previous year. The price fluctuation and impairment risks associated with investment securities are materializing as larger losses. - FY2019-Q2MaterialisedAnnual report
「Investment securities valuation loss 235,665」
A valuation loss on investment securities of ¥235.665 million was recognized in the six-month period ended the second quarter. - FY2019-Q1MaterialisedAnnual report
「Loss on valuation of investment securities: ¥762 thousand」
A valuation loss on investment securities of ¥762,000 was recognized in the three-month period ended the first quarter, and the price fluctuation and impairment risks continued to materialize as losses. - FY2018MaterialisedAnnual report
「During the consolidated fiscal year, impairment losses of ¥293.458 million were recognized on securities, comprising ¥293.458 million on unlisted shares classified as other securities.」
Impairment losses on investment securities increased from ¥140.477 million in the previous fiscal year to ¥293.458 million, continuing to materialize as losses. - FY2018-Q3MaterialisedAnnual report
「Investment securities valuation loss 39,999」
A valuation loss on investment securities of ¥39.999 million was recognized in the nine-month period ended the third quarter. The price fluctuation and impairment risks associated with investment securities continue to materialize as actual losses. - FY2017First statedAnnual report
「Investment securities consist mainly of shares, bonds and partnership investments, and are exposed to the credit risk of issuers and the risk of fluctuations in market prices. In the consolidated fiscal year, impairment losses of ¥140.477 million were recognized.」
The company disclosed the credit and market-price fluctuation risks associated with investment securities, and recognized an impairment loss of ¥140.477 million during the period.